APMA Advocacy Contributes to MIPS Quality Measure Suppression | News | APMA
APMA Advocacy Contributes to MIPS Quality Measure Suppression

July 12, 2021

After hearing from members that certain Part B claims MIPS Quality measure submissions were being rejected by CMS, APMA communicated with CMS about this issue. CMS then realized it had made a processing error regarding these measures and announced that for the 2021 performance period, it is suppressing Part B claims Quality measures 001 (Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)) and 117 (Diabetes: Eye Exam).

CMS indicated that providers who submit one (or both) of these measures will see their total available Quality measure achievement points reduced by 10 points (per measure).


Leave Your Thoughts

Please sign in to leave a comment



Related Resources

The 2022 APMA Virtual Legislative Conference and Advocacy Week

Learn More

APMA Meets with Consultant to Refine Private Insurance Strategy

Learn More

ADVERTISEMENT
Be an advocate for your profession in five minutes or less. Log on today.